RP-HPLC Method Development and Validation for Determination of Tigecycline in Bulk and Pharmaceutical Dosage form

نویسندگان

چکیده

Aims: To develop and validate a new, simple, rapid, precise accurate Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method for the quantitative determination of Tigecycline in bulk pharmaceutical dosage form.
 Study Design:
 Place Duration Study: RBVRR women's college pharmacy, Barkatpura, Hyderabad, between june 2019 july 2020.
 Methodology: The RP-HPLC was developed on Sunsil C18 150 mm x 4.6mm 5µ column using acetonitrile : water (pH maintained at 3.5 with acetic acid) [70:30] as mobile phase flow rate 0.8 ml/min UV detection 250 nm.
 Results: exhibited linearity over concentration range 5-40 µg/mL (R2 > 0.999). analytical showed good precision % RSD below 2. suitable accuracy robustness.
 Conclusion: Validation done per International Conference Harmonization (ICH) Q2R1 guidelines.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms

A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 colum...

متن کامل

RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms

A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 colum...

متن کامل

Development and validation of RP-HPLC method for quantitative determination of imatinib mesylate in bulk drug and pharmaceutical dosage form

The main aim of present work was to develop a simple, precise, rapid and reproducible isocratic reverse phase high performance liquid chromatographic (RP-HPLC) method for the estimation of Imatinib in pure and in tablet dosage form. An isocratic RP-HPLC was performed by utilizing Welchrom C18 column, (250 mm × 4.6 mm i.d., particle size 5 μm) maintained at ambient temperature and mobile phase c...

متن کامل

Development and Validation of a Rp-hplc Method for Determination of Lopinavir in Bulk and Pharmaceutical Dosage Form

A new, simple, precise and accurate RP-HPLC method was developed and validated for the determination of lopinavir in pure and tablet dosage form. The separation was carried out using phenomenex C18 (250 x 4.6 mm, 5 μm particle size) column, with a mobile phase consisting of acetonitrile and phosphate buffer (7.8) in the ratio of 85:15 v/v. The flow rate was set at 1.0 ml/min and detection was m...

متن کامل

Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form

The present study describes a simple, accurate, precise and cost effective UV-Vis Spectroscopic and RP-HPLC method for the estimation of Ibandronate sodium (IBN). The determination of Ibandronate sodium (IBN) was performed by both UV and RP-HPLC method using 215 nm as the determination wavelength. The drug was dissolved in NaOH solution (0.1N NaOH) for estimation in UV and in distilled water fo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of pharmaceutical research international

سال: 2021

ISSN: ['2456-9119']

DOI: https://doi.org/10.9734/jpri/2021/v33i39b32204